About Us

Marianna Volpert

Marianna Volpert


  • Postdoctoral Research Fellow (Cancer Plasticity), APCRC-Q
  • Centre for Genomics and Personalised Health, QUT
  • School of Biomedical Sciences, Faculty of Health, QUT

Contact Details

+61 7 3443 7356


PhD - Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Australia (2014)

BSc Hons (First Class), University of Melbourne, Australia (2009)

BBiomedSc, University of Melbourne, Australia (2008)


Dr Volpert obtained her PhD degree from the University of Melbourne in 2014, where her research focused on identifying molecular determinants of prostate cancer invasiveness. This work led to a Novartis Junior Scientist Award for outstanding oral presentation by a junior member of the Endocrine Society of Australia, as well as the Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria (2014). In 2015, Dr Volpert joined the APCRC-Q to investigate the role of Neuropilin-1 (NRP1) in promoting prostate cancer metastasis and therapy resistance, where she was awarded the Prostate Cancer Foundation of Australia John Mills Young Investigator Award. She has expanded her studies into the breast cancer field and is focused on identifying novel, clinically actionable targets in specific molecular subtypes of triple-negative breast cancer, which currently have few durable targeted therapies. These studies have led to industry collaboration and testing of therapeutic inhibitors in clinically-relevant prostate and breast cancer models. Dr Volpert has extensive experience conducting in vivo preclinical therapeutic trials and has a particular interest in development and implementation of pre-clinical models that faithfully recapitulate key aspects of tumour molecular and therapy-resistant subtypes and tumour microenvironment characteristics. Collectively, her research has led to over $250k in independent funding (PI/CI-A), and over the past 5 years has formed the basis of successful grant applications totaling over $1.7M awarded to her supervisors.

Awards and grants

2021 Movember Research Acceleration Award (Co-Investigator); Accelerated translation of novel therapeutics for castrate-resistant prostate cancer

JJ Richards / In Vitro Technologies Research Excellence Grant


Cancer Program Award for Critical Data Generation, Institute of Health & Biomedical Innovation Cancer Program, Queensland University of Technology


Early Career Researcher Development Scheme, Institute of Health and Biomedical Innovation; Queensland University of Technology


Industry Collaboration Preparedness Pilot Research Support Scheme, Faculty of Health/School of Biomedical Sciences; Queensland University of Technology


The John Mills Young Investigator Award, Prostate Cancer Foundation of Australia


The Sydney Parker Smith Postdoctoral Research Fellowship, Cancer Council Victoria


Endocrine Society of Australia - Novartis Junior Scientist Award


Doctoral thesis ‘An Investigation into the Function of Cysteine-Rich Secretory Protein 3’ nominated for best annual PhD thesis; Pharmacology Department, University of Melbourne


Melbourne Abroad Travel Scholarship, University of Melbourne


Overseas travel scholarship, University of Melbourne


Postgraduate Student Representative, Pharmacology Department, University of Melbourne


Australian Postgraduate Award

Research interests

Prostate cancer, breast cancer, endocrine-driven tumours, therapy-resistance, pre-clinical therapeutic trials, receptor tyrosine kinase signalling

Current research projects

Targeting bypass survival pathways in castration-resistant prostate cancer

Testing novel therapies for molecular subtypes of triple-negative breast cancer

Top publications

Volpert M *, Furic L *¥, Hu J, O’Connor AE, Rebello RJ, Keerthikumar S, Evans J, Merriner DJ, Pedersen J, Risbridger G, McIntyre P, O’Bryan MK¥. Cysteine-rich secretory protein 3 expression drives prostate cancer invasion and progression. Endocr Relat Cancer 27, 415-430 (2020).  *These authors contributed equally to this manuscript.

Yeh MC, Tse B, Fletcher NL, Houston ZH, Lund M, Volpert M, Stewart C, Sokolowski K, Jeet V, Thurecht KJ, Campbell DH, Walsh BJ, Nelson CC & Russell PJ. Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1). European Journal of Nuclear Medicine and Molecular Imaging Research, 10, 46 (2020).

Lim S, Kierzek M, O’Connor AE, Brenker C, Merriner DJ, Okuda H, Volpert M, Gaikwad A, Bianco D, Potter D, Prabhakar R, Strunker T & O’Bryan MK. CRISP2 is a regulator of multiple aspects of sperm function and male fertility. Endocrinology, 160, 915-924 (2019).

Tse B *, Volpert M *, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman M, McPherson S, Roshan-Moniri M, Butler M, Caradec J, Gregory-Evans C, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer E, Jenkins R, Ross A, Karnes R, Den R, Fazli L, Gregory P, Gleave ME, Williams ED, Rennie PS, Buttyan R, Gunter J, Selth L, Russell PJ, Nelson C & Hollier BG. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene, 15;36(24):3417-3427 (2017). *These authors contributed equally to this manuscript.

Evans J, D’Sylva R, Volpert M, Jamsai D, Merriner DJ, Nie G, Salamonsen LA & O’Bryan MK. Endometrial CRISP3 is regulated throughout the mouse estrous and human menstrual cycle and facilitates adhesion and proliferation of endometrial epithelial cells. Biol Reprod, 92(4): p. 99 (2015).

Volpert M, Mangum JE, Jamsai D, D’Sylva R, O’Bryan MK &McIntyre P. Eukaryotic expression, purification and structure/function analysis of native, recombinant CRISP3 from human and mouse. Sci Rep, 4: p. 4217 (2014).

More can be viewed at Pubmed.

More publications are available on PubMed


  • Thomas Tang PhD Candidate, APCRC-Q, IHBI, Queensland University of Technology

Primary supervisor, Mr Yu Hin Tang (PhD candidate)

Associate supervisor, Ms Qiuhua Hu (PhD candidate)

Primary supervisor, Ms Layla-Rose Lynam (MPhil candidate)


Professional memberships and associations


Australian Prostate Cancer Research Centre- Queensland


Prostate Cancer Collaborative Research Alliance


Australian Society for Medical Research (ASMR)


Endocrine Society of Australia